Heron Therapeutics, Inc. (HRTX)
Total Valuation
HRTX has a market cap or net worth of $411.90 million. The enterprise value is $511.12 million.
Market Cap | 411.90M |
Enterprise Value | 511.12M |
Important Dates
The last earnings date was Tuesday, March 12, 2024, after market close.
Earnings Date | Mar 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
HRTX has 150.33 million shares outstanding. The number of shares has increased by 26.87% in one year.
Shares Outstanding | 150.33M |
Shares Change (YoY) | +26.87% |
Shares Change (QoQ) | +4.35% |
Owned by Insiders (%) | 0.89% |
Owned by Institutions (%) | 76.09% |
Float | 122.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.24 |
Forward PS | 2.87 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 4.02 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37
Current Ratio | 2.37 |
Quick Ratio | 1.76 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -218.36 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -50.60% |
Return on Capital (ROIC) | -75.94% |
Revenue Per Employee | $1.01M |
Profits Per Employee | -$877,452 |
Employee Count | 126 |
Asset Turnover | 0.58 |
Inventory Turnover | 1.35 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.50% in the last 52 weeks. The beta is 1.68, so HRTX's price volatility has been higher than the market average.
Beta (1Y) | 1.68 |
52-Week Price Change | +70.50% |
50-Day Moving Average | 2.62 |
200-Day Moving Average | 1.64 |
Relative Strength Index (RSI) | 49.79 |
Average Volume (30 Days) | 3,089,300 |
Short Selling Information
The latest short interest is 25.43 million, so 16.91% of the outstanding shares have been sold short.
Short Interest | 25.43M |
Short Previous Month | 24.53M |
Short % of Shares Out | 16.91% |
Short % of Float | 20.83% |
Short Ratio (days to cover) | 8.61 |
Income Statement
In the last 12 months, HRTX had revenue of $127.04 million and -$110.56 million in losses. Loss per share was -$0.80.
Revenue | 127.04M |
Gross Profit | 61.94M |
Operating Income | -110.62M |
Pretax Income | -110.56M |
Net Income | -110.56M |
EBITDA | -107.16M |
EBIT | -110.06M |
Loss Per Share | -$0.80 |
Balance Sheet
The company has $80.41 million in cash and $179.63 million in debt, giving a net cash position of -$99.22 million or -$0.66 per share.
Cash & Cash Equivalents | 80.41M |
Total Debt | 179.63M |
Net Cash | -99.22M |
Net Cash Per Share | -$0.66 |
Equity / Book Value | -33.97M |
Book Value Per Share | -0.23 |
Working Capital | 109.09M |
Cash Flow
In the last 12 months, operating cash flow was -$58.79 million and capital expenditures -$1.53 million, giving a free cash flow of -$60.32 million.
Operating Cash Flow | -58.79M |
Capital Expenditures | -1.53M |
Free Cash Flow | -60.32M |
FCF Per Share | -$0.44 |
Margins
Gross margin is 48.75%, with operating and profit margins of -87.07% and -87.02%.
Gross Margin | 48.75% |
Operating Margin | -87.07% |
Pretax Margin | -87.02% |
Profit Margin | -87.02% |
EBITDA Margin | -84.35% |
EBIT Margin | -86.63% |
FCF Margin | -47.48% |
Dividends & Yields
HRTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -26.87% |
Shareholder Yield | -26.87% |
Earnings Yield | -26.84% |
FCF Yield | -14.64% |
Analyst Forecast
The average price target for HRTX is $5.00, which is 80.51% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.00 |
Price Target Difference | 80.51% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 20.97% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 13, 2014. It was a reverse split with a ratio of 1:20.
Last Split Date | Jan 13, 2014 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
HRTX has an Altman Z-Score of -11.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -11.5 |
Piotroski F-Score | 2 |